z-logo
open-access-imgOpen Access
Microscopic and functional changes observed with dynamic optical coherence tomography for severe refractory atopic dermatitis treated with dupilumab
Author(s) -
Manfredini Marco,
Liberati Serena,
Ciardo Silvana,
Bonzano Laura,
Guanti Mario,
Chester Johanna,
Kaleci Shaniko,
Pellacani Giovanni
Publication year - 2020
Publication title -
skin research and technology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.521
H-Index - 69
eISSN - 1600-0846
pISSN - 0909-752X
DOI - 10.1111/srt.12868
Subject(s) - dupilumab , medicine , atopic dermatitis , eczema area and severity index , refractory (planetary science) , dermatology , pathology , physics , astrobiology
Abstract Background Atopic dermatitis (AD) is a chronic inflammatory disease. Recently, dupilumab was approved for moderate‐to‐severe AD. D‐OCT is a noninvasive tool for the characterization of skin diseases. Objective To describe the changes observed with D‐OCT in lesional and clinically healthy skin of patients with refractory severe AD under dupilumab treatment. Methods We analyzed AD lesions and healthy skin by D‐OCT. Clinical scores of AD severity were assessed at baseline (T0) and after 1 and 3 months of treatment (T1, T2). Descriptive statistics, chi‐square test, and t test were used to compare the analyzed parameters over time and between AD lesions and clinically healthy skin. Results At baseline, average EASI was 45.7. During the follow‐up, EASI75 and EASI90 were achieved in 57% and 36% of patients at T1 and 100% and 86% of patients at T2, respectively. Lesional skin D‐OCT parameters related to epidermal remodeling and inflammation evidenced a significant improvement after 1 month of treatment. In clinically healthy skin, D‐OCT parameters improved significantly after 3 months of treatment, especially for collagen remodeling and inflammation. Conclusion The study demonstrates that the clinical improvement of severe AD patients under dupilumab treatment is correlated with specific D‐OCT changes of patients’ lesional and clinically healthy skin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here